Andrew Huberman· PhD
Um, and then some of these alkyoids are heavily hitting the adinuric receptors, which is our stimulant sort of activity centers. Uh, our fight orflight sort of system, if you will.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Um, and then some of these alkyoids are heavily hitting the adinuric receptors, which is our stimulant sort of activity centers. Uh, our fight orflight sort of system, if you will.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.